Multiple myeloma is no longer a dead end: Dr Pravas Mishra Shahid Akhter, editor, ETHealthworld spoke to Dr. Pravas Mishra, Director, Hemato-Oncology & BMT, Max Hospital, New Delhi to know more about the trends and latest advancements in the management of Multiple Myeloma.
Read More
”; However, it is advisable that certain guidelines should be followed while writing on the chosen topic like,” select a topic of your interest” thesis should be written” do thorough research” give an outline” prepare a rough draft” edit your paper” prepare a final copyCommon errors& While preparing research papers, students commit several mistakes which […]
Read More Assisted Reproductive Technology Does Not Raise Risk of Ovarian Cancer, Study Indicates Women who use assisted reproductive technology to help them conceive a child appear not to be at an increased risk of developing ovarian cancer, a nationwide study conducted in the Netherlands has found. The study, “Long-Term Risk of Ovarian Cancer and Borderline Tumors […]
Read More
atbtherapeutics Initiates Agreement With iBio CDMO to Manufacture Game-changer atbodies to … MARCHE-EN-FAMENNE, Belgium–(BUSINESS WIRE)–atbtherapeutics, a pioneering biopharmaceutical company building an oncology pipeline using its antibody–toxin-bioengineered “atbody”, announces that it has entered a long-term manufacturing agreement with iBio CDMO, a global leader in plant-based biologics manufacturing located in the US. In this agreement, atbtherapeutics and […]
Read More Chemistry Nobel Honors CRISPR, an “Essential” Tool for Cancer [unable to retrieve full-text content] Two scientists who pioneered the site-specific genome-editing technology that is contributing to innovative and breathtaking cancer therapies were …Published at Wed, 02 Dec 2020 01:07:52 +0000
Read More
Dana-Farber to present more than 40 research studies at 2020 ASH Annual Meeting Two Dana-Farber studies selected for inclusion in the official ASH press program Dana-Farber Cancer Institute researchers will present more than 40 research studies at the virtual 62nd American Society of Hematology (ASH) Annual Meeting on December 5-8, including two studies that were […]
Read More